{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "",
          "alt": "",
          "position": ""
        },
        "variant_string_id": "LRRK2 RefPosAlt"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene cause dominantly inherited Parkinsonâ€™s disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that mutations in LRRK2 cause PD, which is relevant to the functional assay."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Manipulating activity by replacing the kinase domain with a Fkinase-dead_ version blocks inclusion body formation and strongly delays cell death.",
          "judgment": "Yes",
          "reasoning": "The paper uses a kinase activity assay, which is relevant to the disease mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls were not explicitly mentioned, but the assay was previously validated (Step 3b).",
          "judgment": "Yes",
          "reasoning": "The paper does not mention basic controls, but Step 3b indicates that the assay has been previously validated."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No OddsPath calculation was performed (Sub-step 4b).",
          "judgment": "Yes",
          "reasoning": "The paper does not calculate an OddsPath value for this variant."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence strength is PS3_supporting due to the use of a kinase activity assay, which models the disease mechanism defined in Step 1, and the fact that basic controls were not explicitly mentioned but the assay was previously validated."
    }
  ]
}